Barinthus Biotherapeutics plc American Depositary Shares (BRNS) Stock Price

BRNSStock

$0.66−49.11%52W

Market Cap$26.96M

P/E—

PEG Ratio—

Div yield—

Beta-0.37

BRNS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-13.02%

Price vs S&P 500 (4W)2.76%

VGM Score50.16

Book Value / Share (Quarterly)$1.82

P/TBV (Annual)0.46x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)282.25%

Cash Flow / Share (Quarterly)$-1.18

Price vs S&P 500 (YTD)-25.61%

Net Profit Margin (TTM)-54.21%

EPS (TTM)$-1.12

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-1.12

Revenue Growth (5Y)16.92%

EPS (Annual)$-1.64

ROI (Annual)-89.52%

Net Profit Margin (5Y Avg)-5777.69%

Cash / Share (Quarterly)$1.72

ROA (Last FY)-67.67%

EBITD / Share (TTM)$-1.07

ROE (5Y Avg)-38.75%

Operating Margin (TTM)-62.66%

Cash Flow / Share (Annual)$-1.18

P/B Ratio0.36x

P/B Ratio (Quarterly)0.35x

Net Income / Employee (Annual)$-4,744,900

Net Interest Coverage (TTM)-15.07x

ROA (TTM)-38.90%

EPS Incl Extra (Annual)$-1.64

Current Ratio (Annual)7.76x

Quick Ratio (Quarterly)5.72x

3-Month Avg Trading Volume0.06M

52-Week Price Return-49.11%

EV / Free Cash Flow (Annual)-22.91x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.47

P/S Ratio (Annual)1.59x

Asset Turnover (Annual)0.09x

52-Week High$1.83

Operating Margin (5Y Avg)-6672.17%

EPS Excl Extra (Annual)$-1.64

CapEx CAGR (5Y)-33.75%

26-Week Price Return-1.78%

Quick Ratio (Annual)7.30x

13-Week Price Return-12.21%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)6.05x

Enterprise Value$-42.06M

Revenue / Share Growth (5Y)13.60%

Asset Turnover (TTM)0.08x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-409.03%

Cash / Share (Annual)$1.72

3-Month Return Std Dev71.71%

Net Income / Employee (TTM)$-3,236,000

ROE (Last FY)-89.52%

EPS Basic Excl Extra (Annual)$-1.64

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.12

Receivables Turnover (Annual)0.27x

ROI (TTM)-49.57%

P/S Ratio (TTM)1.59x

Pretax Margin (5Y Avg)-5880.15%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.47

Price vs S&P 500 (52W)-67.42%

Year-to-Date Return-13.86%

5-Day Price Return-2.73%

EPS Normalized (Annual)$-1.64

ROA (5Y Avg)-31.22%

Net Profit Margin (Annual)-408.00%

Month-to-Date Return8.12%

Cash Flow / Share (TTM)$-1.89

EBITD / Share (Annual)$-1.60

Operating Margin (Annual)-454.07%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-38.74%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.12

P/TBV (Quarterly)0.44x

P/B Ratio (Annual)0.37x

Pretax Margin (TTM)-54.33%

Book Value / Share (Annual)$1.82

Price vs S&P 500 (13W)-15.01%

Beta-0.37x

Revenue / Share (TTM)$0.00

ROE (TTM)-49.57%

52-Week Low$0.51

gGradeB

mGradeD

vgmGradeC

BRNS Earnings Surprise History

Q2 25-0.52est. -0.33

Q3 25-0.24est. -0.40

Q4 25-0.27est. -0.34

Q1 26-0.14est. -0.28

Q2 26-0.26est. -0.28

BRNS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
BRNSBarinthus Biotherapeutics plc American Depositary Shares	—	B	D	$0.66
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Barinthus Biotherapeutics plc American Depositary Shares

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapies designed to treat chronic infectious diseases, autoimmune disorders, and cancer. The company operates a single business segment focused on the research and development of immunotherapies and vaccine candidates.